Skip to main content
Fig. 4 | BMC Microbiology

Fig. 4

From: Bifidobacterium longum SX-1326 ameliorates gastrointestinal toxicity after irinotecan chemotherapy via modulating the P53 signaling pathway and brain-gut axis

Fig. 4

B. longum SX-1326 balances dysregulated gut microbiota caused by chemotherapy. A Fecal shape scoring of mice in each group; B Blood stool scoring of mice in each group; C Colorectal length of mice in each group; D Disease activity index scores for each group of mice (E) Shannon index; F Simspon index; G Pielou_e analysis; H PCoA diagram; I Venn diagram; J Tenericutes; K Dehalobacterium; L Ruminnococcus; M Mucispirillum. Experimental group: C: normal control group; M: colorectal cancer model group; B: Bifidobacterium longum SX-1326 group; I: Irinotecan chemotherapy group; U: Bifidobacterium longum SX-1326 plus irinotecan dosing group. Data are expressed as mean ± SD, *p < 0.05, **p < 0.01

Back to article page

BMC Microbiology

ISSN: 1471-2180

Contact us